Cureskin secures $20 million in Series B funding

The fresh funding fuels the company’s vision to widen access to quality dermatological care in India leveraging AI built over millions of datasets Cureskin, an AI-driven dermatology platform that provides clinically validated skin & hair health solutions, has raised Series B funding of $20 million. The round was led by HealthQuad along with participation from existing marquee investors including JSW Ventures, Khosla Ventures and Sharrp Ventures. The latest investment brings Cureskin's total funding to $26 million, further fuelling its vision to widen access to quality dermatological care in India. Cureskin is expanding the skin and hair care market by bridging this gap by leveraging AI to scale the reach of dermatologists. Through its mobile app, Cureskin has treated over 15 Lakh customers so far for various conditions such as acne, hyper-pigmentation, post-acne issues, hair loss etc, with over 80% of customers in Tier II and III regions.  “We are delighted to have earned the backing of HealthQuad alongside our existing partners”, expressed Guna Kakulapati, CEO and Co-founder, Cureskin. “This investment reaffirms the growing demand for accessible expertise and quality care to solve skin and hair problems for people in India. These funds will help further enhance our AI capabilities, accelerate our growth and expand solution offerings. We aim to provide optimal skin and hair health to millions of individuals across the country.”  Dr Pinak Shrikhande, MD, HealthQuad said, “Lack of qualified dermatologists in Tier III+ towns and lack of product knowledge leads to ineffective self-treatments. Cureskin is a comprehensive digital-first platform focused on customised skin and hair care treatments solving for the lack of access to dermatologists with a deep AI-led diagnosis while providing high-quality outcome-driven regimens at affordable prices. We are proud to be partners in Cureskin’s journey to create impact as it scales.”  "We are excited to be part of Cureskin and are deeply aligned with its vision of creating impact through widening access to qualified dermatological care pan-India. With more than 70 per cent of the company’s users currently coming from Tier III+ locations, Cureskin is aligned with HealthQuad’s mission of solving the accessibility, affordability and quality issues in healthcare in India. We remain committed to partnering with transformational digital-first companies creating impact for the underserved,” added Charles–Antoine Janssen, Chief Investment Officer, HealthQuad.  JSW Ventures Managing Partner Sachin Tagra said, "The company has demonstrated exemplary execution capabilities. This capital will help the company continue scaling its operations, innovate further on AI development to build a stronger technology moat, and expand its distribution capabilities."